Breaking down regulatory barriers could deliver step change improvements to prostate cancer outcomes 21 Mar 2023 We have seen major advances in prostate cancer research, and people with the disease are living longer than ever. However, more needs to be done to harness scientific discoveries and bring innovative drugs to patients. Here we discuss the regulatory landscape and reforms needed to ensure patients can access the most innovative treatments as quickly as possible. Find out more Show/Hide
ASCO 2022: ICR researchers hit the headlines with innovative approaches to cancer treatment and care 08 Jun 2022 The first in-person ASCO conference since the start of the Covid-19 pandemic took place in Chicago over the weekend. Many researchers from the ICR and The Royal Marsden presented their work in the form of talks or posters. Here we look back over some of our highlights of this year’s meeting. Find out more Show/Hide
“I’m 33 years old, and there’s still so much I want to do” - Kate's story 06 Jul 2021 Kate Parker was diagnosed with stage 4 bowel cancer just before her 30th birthday. She tells us what more treatment options mean for her. Find out more Show/Hide
International Medical Physics Week 2021 – how the ICR has pioneered ultrasound research to study and treat cancer 29 Apr 2021
Prostate Cancer Awareness Month 2020: Immunotherapy, state-of-the-art radiotherapy, olaparib and PSA screening 24 Mar 2020
NCRI 2019: What patients want and new territory in cancer research – looking back over a packed three days 06 Nov 2019